University of California researchers are testing psilocybin for chronic back pain, eating disorders, and doctor burnout — and one of these trials is expected to show significant positive results before 2028.
All three running trials in non-psychiatric indications: UCSF (chronic pain, anorexia), UCLA (psilocybin+CBT adjunct), UCSD (physician burnout). At least one achieving significance within 18 months is probable given multiple concurrent trials. 76% reflects high base rate for portfolio of trials.